CN101512016B - 可检测的核酸标签 - Google Patents

可检测的核酸标签 Download PDF

Info

Publication number
CN101512016B
CN101512016B CN200780032387.7A CN200780032387A CN101512016B CN 101512016 B CN101512016 B CN 101512016B CN 200780032387 A CN200780032387 A CN 200780032387A CN 101512016 B CN101512016 B CN 101512016B
Authority
CN
China
Prior art keywords
nucleic acid
protein
fusion protein
structural domain
binding structural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200780032387.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN101512016A (zh
Inventor
皮艾特罗·奇切里
杰里米·亨特
吉恩-迈克尔·A·莱利亚斯
迈克·莫里森
丹尼尔·特莱柏
利萨·M·沃迪科卡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ambit Bioscience Corp
Original Assignee
Ambit Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambit Bioscience Corp filed Critical Ambit Bioscience Corp
Publication of CN101512016A publication Critical patent/CN101512016A/zh
Application granted granted Critical
Publication of CN101512016B publication Critical patent/CN101512016B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2522/00—Reaction characterised by the use of non-enzymatic proteins
    • C12Q2522/10—Nucleic acid binding proteins
    • C12Q2522/101—Single or double stranded nucleic acid binding proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/101—Nucleic acid detection characterized by the use of physical, structural and functional properties radioactivity, e.g. radioactive labels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/113—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being electroactive, e.g. redox labels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
CN200780032387.7A 2006-06-30 2007-06-29 可检测的核酸标签 Active CN101512016B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80642206P 2006-06-30 2006-06-30
US60/806,422 2006-06-30
PCT/US2007/015089 WO2008005310A2 (en) 2006-06-30 2007-06-29 Detectable nucleic acid tag

Publications (2)

Publication Number Publication Date
CN101512016A CN101512016A (zh) 2009-08-19
CN101512016B true CN101512016B (zh) 2016-08-03

Family

ID=38895122

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780032387.7A Active CN101512016B (zh) 2006-06-30 2007-06-29 可检测的核酸标签

Country Status (10)

Country Link
US (2) US9110054B2 (https=)
EP (2) EP2405272B1 (https=)
JP (2) JP5415264B2 (https=)
KR (1) KR20090034930A (https=)
CN (1) CN101512016B (https=)
AU (1) AU2007269786A1 (https=)
CA (1) CA2656192C (https=)
IL (1) IL196258A0 (https=)
MX (1) MX2009000044A (https=)
WO (1) WO2008005310A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3147281A1 (en) 2008-03-17 2017-03-29 Ambit Biosciences Corporation Quinazoline derivatives as raf kinase modulators and methods of use thereof
MY159327A (en) 2009-02-27 2016-12-25 Ambit Biosciences Corp Jak kinase modulating quinazoline derivatives and methods of use thereof
JP2012524907A (ja) * 2009-04-24 2012-10-18 ディスカヴァーエックス コーポレイション 検出可能なタンパク質を用いた細胞分析
MX2012001974A (es) 2009-08-19 2012-04-11 Ambit Biosciences Corp Compuestos de biarilo y metodos de uso de los mismos.
SG179200A1 (en) * 2009-09-16 2012-04-27 Univ Massey Fusion polypeptides and uses thereof
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
US9296722B2 (en) 2010-05-27 2016-03-29 Ambit Biosciences Corporation Azolyl urea compounds and methods of use thereof
WO2011150201A2 (en) 2010-05-27 2011-12-01 Ambit Biosciences Corporation Azolyl amide compounds and methods of use thereof
EP2611812A1 (en) 2010-09-01 2013-07-10 Ambit Biosciences Corporation Thienopyridine and thienopyrimidine compounds and methods of use thereof
WO2012030948A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Quinazoline compounds and methods of use thereof
AU2011296078B2 (en) 2010-09-01 2015-06-18 Ambit Biosciences Corporation An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
EP2663553B1 (en) 2010-09-01 2015-08-26 Ambit Biosciences Corporation Quinoline and isoquinoline derivatives for use as jak modulators
EP2611793A1 (en) 2010-09-01 2013-07-10 Ambit Biosciences Corporation 2-cycloquinazoline derivatives and methods of use thereof
US20130225614A1 (en) 2010-09-01 2013-08-29 Ambit Biosciences Corporation 4-azolylaminoquinazoline derivatives and methods of use thereof
EP2611448A1 (en) 2010-09-01 2013-07-10 Ambit Biosciences Corporation 7-cyclylquinazoline derivatives and methods of use thereof
WO2012030924A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Azolopyridine and azolopyrimidine compounds and methods of use thereof
AU2012322095B2 (en) 2011-10-14 2017-06-29 Ambit Biosciences Corporation Heterocyclic compounds and use thereof as modulators of type III receptor tyrosine kinases
CN104156739B (zh) * 2013-05-14 2019-09-10 上海亨臻实业有限公司 电子标签亲和配体库及用途
GB201409282D0 (en) * 2014-05-23 2014-07-09 Univ Sydney Tech Sequencing process
WO2016008120A1 (zh) * 2014-07-16 2016-01-21 中国科学技术大学 基于核酸序列的蛋白质相互作用检测方法
EP3183580B1 (en) 2014-08-21 2025-03-26 Eurofins DiscoverX Corporation Homogenous thermal shift ligand binding assay
US10829484B2 (en) 2015-07-28 2020-11-10 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP4354140A3 (en) 2016-02-26 2024-07-24 The Board of Trustees of the Leland Stanford Junior University Multiplexed single molecule rna visualization with a two-probe proximity ligation system
IL266197B2 (en) 2016-10-24 2024-03-01 Geneinfosec Inc Hiding information contained within nucleic acids
EP3548007A4 (en) 2016-12-01 2020-08-12 Ignyta, Inc. METHOD OF TREATMENT OF CANCER
JP7502787B2 (ja) 2018-04-09 2024-06-19 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー インサイチュ遺伝子配列決定の方法
KR102798620B1 (ko) 2018-06-07 2025-04-22 암젠 인크 단백질-폴리뉴클레오티드 접합체에 대한 검출 검정
CN109709080B (zh) * 2018-09-28 2020-06-02 山东大学 一种光控示踪剂在探测蛋白质的寡聚状态中的应用
AU2019392906A1 (en) * 2018-12-07 2021-07-22 Octant, Inc. Systems for protein-protein interaction screening
AU2020310837A1 (en) * 2019-07-08 2022-02-24 Inscripta, Inc. Increased nucleic acid-guided cell editing via a LexA-Rad51 fusion protein
KR102319229B1 (ko) * 2020-03-03 2021-10-28 차의과학대학교 산학협력단 반복유산 진단을 위한 분석방법 및 키트
US11091524B1 (en) 2020-04-22 2021-08-17 Houston Gene Therapeutics Llc Compositions for treatment of vascular disease
AU2021318522A1 (en) * 2020-07-28 2023-03-23 Protillion Biosciences, Inc. Systems and methods for assaying a plurality of polypeptides
CN112126680B (zh) * 2020-09-27 2022-10-14 北京大学 基于荧光定量pcr筛选痕量内分泌干扰物的试剂盒及方法
CN116793750B (zh) * 2023-06-30 2024-09-20 宁波大学 一种高细菌检测特异性的atp荧光检测拭子及其使用方法
WO2025189030A1 (en) 2024-03-07 2025-09-12 Stellaromics, Inc. Methods and systems for volumetric imaging
WO2025209553A1 (en) * 2024-04-02 2025-10-09 Ningbo Leadart Biotechnologies Co., Ltd. System and method for detecting the interaction between reactive probes and proteins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE332368T1 (de) 1997-01-21 2006-07-15 Gen Hospital Corp Selektion von proteinen mittels rns-protein fusionen
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
GB9724829D0 (en) 1997-11-21 1998-01-21 Muller Rolf Transcription factor
US20030027214A1 (en) * 1999-02-17 2003-02-06 Kamb Carl Alexander Methods for substrate-ligand interaction screening
CA2398790A1 (en) * 2000-01-28 2001-08-02 The Scripps Research Institute Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
EP1138781A3 (en) * 2000-03-31 2004-07-14 Health Research, Inc. Method for Quantifying DNA binding activity of DNA binding proteins
WO2002050259A2 (en) * 2000-12-18 2002-06-27 National Research Council Of Canada Compositions, methods and kits for identifying protein-protein interaction disrupting agents
DE60212642T2 (de) 2001-04-10 2007-06-14 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Verfahren zur verwendung von o6-alkylguanin-dna-alkyltransferasen
AU2003222178A1 (en) 2002-03-29 2003-10-13 Nugen Technologies, Inc. Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
US20030186221A1 (en) 2002-04-02 2003-10-02 Lockhart David J. Phage display affinity filter and forward screen
GB0212652D0 (en) * 2002-05-31 2002-07-10 Univ Bristol Screening Assay
WO2004035732A2 (en) * 2002-08-29 2004-04-29 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use
US20050015337A1 (en) 2002-09-17 2005-01-20 Washington Keith Anthony Address billing system
JP4991291B2 (ja) 2003-06-20 2012-08-01 ディスカバーエクス コーポレイション タンパク質結合を検出するための検定法およびキット
AU2005204428A1 (en) 2004-01-07 2005-07-28 Ambit Biosciences Corporation Conjugated small molecules

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Escalante CR."Structure of IRF-1 with bound DNA reveals determinants of interferon regulation.".《Nature》.1998,第391卷(第6662期),第105页图4. *
Kuprash DV."Homodimer of p50 (NF kappa B1) does not introduce a substantial directed bend into DNA according to three different experimental assays.".《Nucleic Acids Res》.1995,第23卷(第2期),第427页右栏最后1段. *
Nehyba J."Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.".《Oncogene》.1997,第14卷(第24期),第2895页右栏第2段. *
Seong GH."Atomic force microscopy identification of transcription factor NFkappaB bound to streptavidin-pin-holding DNA probe.".《Anal Biochem》.2002,第309卷(第2期),第242页右栏第1-2段、第243页图2. *

Also Published As

Publication number Publication date
EP2044219A2 (en) 2009-04-08
JP2009542211A (ja) 2009-12-03
US20150377886A1 (en) 2015-12-31
JP2014057594A (ja) 2014-04-03
CN101512016A (zh) 2009-08-19
IL196258A0 (en) 2011-08-01
US9110054B2 (en) 2015-08-18
EP2044219B1 (en) 2013-05-22
KR20090034930A (ko) 2009-04-08
EP2405272B1 (en) 2015-01-14
JP6038759B2 (ja) 2016-12-07
AU2007269786A1 (en) 2008-01-10
EP2405272A1 (en) 2012-01-11
US10324092B2 (en) 2019-06-18
MX2009000044A (es) 2009-01-23
CA2656192A1 (en) 2008-01-10
JP5415264B2 (ja) 2014-02-12
WO2008005310A3 (en) 2008-08-21
WO2008005310A2 (en) 2008-01-10
CA2656192C (en) 2016-05-03
US20090053701A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
CN101512016B (zh) 可检测的核酸标签
CN115244185A (zh) 使用探针对连接的原位rna分析
JP4959691B2 (ja) 繰り返し調製可能なタンパク質アレイ
US10132801B2 (en) Method for screening new drug candidate inhibiting target protein-protein interaction for development of first-in-class drug
JP5441978B2 (ja) タンパク質結合を検出するための検定法およびキット
US20160097050A1 (en) Devices and methods for display of encoded peptides, polypeptides, and proteins on dna
US20210269863A1 (en) Systems and methods for proteomic activity analysis using dna-encoded probes
CN102459642A (zh) 采用可检测蛋白质的细胞测定法
EP1490682A1 (en) Detection of dna-binding proteins
US12416100B2 (en) Devices and methods for display of encoded peptides, polypeptides, and proteins on DNA
CN106062560A (zh) 使用特异性抗体检测蛋白质修饰的方法
US20170322206A1 (en) Integrated compound discovery systems and methods
JP5739807B2 (ja) 受容体チロシンキナーゼアッセイ
US20240327902A1 (en) Methods for detecting and analysis of proteins
Recchia et al. A modular toolbox for in cellulo screening of small molecule inhibitors targeting chromatin reader domains

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: DISCOVER REX CO., LTD.

Free format text: FORMER OWNER: AMBIT BIOSCIENCES CORP.

Effective date: 20110804

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20110804

Address after: American California

Applicant after: Ambit Biosciences Corp.

Address before: American California

Applicant before: Ambit Biosciences Corporation

C14 Grant of patent or utility model
GR01 Patent grant